1. Home
  2. IZEA vs NEPH Comparison

IZEA vs NEPH Comparison

Compare IZEA & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IZEA Worldwide Inc.

IZEA

IZEA Worldwide Inc.

N/A

Current Price

$2.48

Market Cap

50.3M

ML Signal

N/A

Logo Nephros Inc.

NEPH

Nephros Inc.

N/A

Current Price

$3.66

Market Cap

49.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
IZEA
NEPH
Founded
2006
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
50.3M
49.4M
IPO Year
2010
2004

Fundamental Metrics

Financial Performance
Metric
IZEA
NEPH
Price
$2.48
$3.66
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
★ $6.25
AVG Volume (30 Days)
★ 33.0K
18.3K
Earning Date
11-11-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
100.00
★ 1000.00
EPS
N/A
★ 0.12
Revenue
★ $20,099,695.00
$18,789,000.00
Revenue This Year
$12.84
$17.81
Revenue Next Year
$20.57
$15.90
P/E Ratio
★ N/A
$32.42
Revenue Growth
N/A
★ 32.67
52 Week Low
$2.38
$2.66
52 Week High
$5.86
$6.42

Technical Indicators

Market Signals
Indicator
IZEA
NEPH
Relative Strength Index (RSI) 28.97 37.63
Support Level N/A $3.19
Resistance Level $3.85 $3.78
Average True Range (ATR) 0.12 0.23
MACD 0.00 -0.08
Stochastic Oscillator 23.64 0.00

Price Performance

Historical Comparison
IZEA
NEPH

About IZEA IZEA Worldwide Inc.

IZEA Worldwide Inc is a full-service creator economy agency powered by proprietary ZED technology, with a mission to make Creator Economy solutions for marketers. It does this by lighting up the Creator Economy with IZEA's strategies, campaigns, and solutions that build brands and drive demand. Since launching the industry's first-ever influencer marketing platform in 2006, IZEA has facilitated nearly 4 million collaborations between brands and creators.

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of revenue from product sales and a small amount from royalty revenue and other revenues.

Share on Social Networks: